[논문] Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07
Journal of Clinical Oncologyㅣ2022
[논문] A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases
Clinical Colon Cancer ㅣ 2020
[논문] Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment
Oncotarget ㅣ 2017
[논문] Relationship between insulin-like growth factor axis gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX
